SecBot SecBot
EFFECT ·Filed Aug 4, 2026

NRXS

Neuraxis, INC
BEARISH
Impact 6/10
Horizondays Processed2mo ago SEC9999999995-26-002528
IPO/offering going effective
Actionable Insight ▼ Bearish

Monitor for a prospectus supplement or takedown announcement, which would signal the company's intent to raise capital. The going-concern reference in the prior filing makes near-term equity issuance likely. Traders should watch for price weakness on any offering announcement.

DirectionBearish
Confidencehigh
Horizondays
Latest settled — T+20d
NRXS ▼ -17.12% at T+20d
SHORT call ✓ call won +17.12% · α vs SPY +15.88% · entry $7.01 → $5.81
Next anchor: T+60d tomorrow
Latest observation: T+57 -48.73% FF3 residual α
Entry = T+0 close
Aug 4, 2026
via day close
T+1d
-3.14%
call +3.14% · α +2.94%
$6.79
settled 3mo ago
T+5d
-9.42%
call +9.42% · α +9.32%
$6.35
settled 3mo ago
T+20d
-17.12%
call +17.12% · α +15.88%
$5.81
settled 8w ago
T+60d
Pending
tomorrow

Price Chart

Loading chart...

Executive Summary

Neuraxis's S-3 shelf registration (File No. 333-297651) became effective on August 3, 2026, allowing the company to sell securities at any time. This creates a potential dilution overhang, especially given the prior S-3/A filing disclosed a going-concern audit opinion, signaling ongoing financial risk. The shelf effectiveness, combined with the company's small $78M market cap, raises the likelihood of near-term capital raising activity.

Key Facts

  • S-3 shelf registration (File No. 333-297651) became effective on August 3, 2026.
  • Company can now sell securities at any time, creating a dilution overhang.
  • Prior S-3/A filing disclosed a going-concern explanatory paragraph in the auditor's report.
  • Market cap is approximately $78M, making any offering potentially dilutive.

Financial Impact

Potential dilution from future offerings; no specific amount disclosed in the EFFECT filing.

dilutionshare count

Risk Factors

  • Dilution from future share issuance
  • Going-concern risk highlighted in prior filing
  • Small market cap amplifies impact of any offering

Market Snapshot

Exchange
NYSE
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-002528
Document: 9999999995-26-002528-index.html9999999995-26-002528
Document: 9999999995-26-002528.txt9999999995-26-002528
14 reports for NRXS
Performance horizon
33% Hit rate @ T+20 1 of 3 directional calls Went positive at some point 2 of 3 best @ T+20▲ +4.14%Jul 30, 2026
Filters
Rows
Reports for NRXS — sortable, filterable
TypeNow
Oct 14, 2026
12d ago
8-K
NEUTRAL ★ 2/10
$7.74awaiting T+20—$7.25 (−6.33%)
Aug 19, 2026
9w ago
8-K
NEUTRAL ★ 2/10
$6.27 $7.61▲ +21.37%▲ +21.37%$7.25 (+15.63%)
Aug 11, 2026
10w ago
Press Release
MIXED ★ 5/10
$6.35 $5.73▼ −9.76%▼ −8.70%$7.25 (+14.17%)
Aug 4, 2026
12w ago
EFFECT
BEARISH ★ 6/10
$7.01 $5.81▲ +17.12%▲ +15.88%$7.25 (−3.42%)
Jul 30, 2026
12w ago
S-3/A
BEARISH ★ 6/10
$6.28 $6.02▲ +4.14%▲ +8.11%$7.25 (−15.45%)
Jul 10, 2026
15w ago
8-K
NEUTRAL ★ 2/10
$7.14 $7.09▼ −0.70%▼ −3.13%$7.25 (+1.54%)
May 12, 2026
23w ago
Press Release
BULLISH ★ 7/10
$8.27 $6.80▼ −17.78%▼ −16.05%$7.25 (−12.33%)
May 5, 2026
24w ago
Press Release
NEUTRAL ★ 1/10
$8.69 $7.01▼ −19.33%▼ −24.29%$7.25 (−16.57%)
Apr 28, 2026
25w ago
DEFA14A
NEUTRAL ★ 4/10
$7.44 $7.29▼ −2.02%▼ −8.06%$7.25 (−2.55%)
Apr 21, 2026
26w ago
8-K
BULLISH ★ 7/10
$7.51 $7.25▼ −3.46%▼ −6.63%$7.25 (−3.46%)
Showing 10 of 14

US Market Status

Market Closed — Opens in 5h 28m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 4, 2026